Menú

Filtros

  • Resultados obtenidos en

Premier RightSign COVID-19 IgG/IgM Test Kit CLIA Waived 20/Bx

Premier RightSign RT-CV19-20 COVID-19 IgG/IgM Test Kit

Laboratory / Rapid Diagnostic Test Kit / 1397131 | Premier Biotech - INGM-MC42
  2. /
  3. Insumos y equipos pequeños
  4. /
  5. Búsqueda de insumos
  6. /
  7. Categoría: Laboratory
  8. /
  9. Premier RightSign COVID-19 IgG/IgM Test Kit CLIA Waived 20/Bx
Premier RightSign COVID-19 IgG/IgM Test Kit CLIA Waived 20/Bx
Comparar
  • Categoría:
    Laboratory / Rapid Diagnostic Test Kit / Respiratory
  • UNSPSC:
    41116100

  • Premier RightSign COVID-19 IgG/IgM Test Kit CLIA Waived 20/Bx 1397131 | Premier Biotech - INGM-MC42

  • Descripción:
    Premier RightSign COVID-19 IgG/IgM Test Kit CLIA Waived 20/Box
  • Categoría:
    Laboratory / Rapid Diagnostic Test Kit
  • UNSPSC:
    41116100
  • Opciones de empaque (1)
    • Discontinuado

Descripción del producto Resumen de las funciones del producto

  • • This Test Has Not Been FDA Cleared Or Approved;

  • • This Test Is Authorized By FDA Under An Emergency Use Authorization (EUA) For Use By Authorized Laboratories Only. Authorized Laboratories Include Laboratories Certified Under The Clinical Laboratory Improvement Amendments Of 1988 (CLIA), 42 U.S.C. 263a, That Meet Requirements To Perform Moderate Or High Complexity Test, When The Specimens Used Are Serum, Plasma, Or Venous Whole Blood. Testing Of Fingerstick Whole Blood Specimens Is Limited To Laboratories Certified Under The Clinical Laboratory Improvement Amendments Of 1988 (CLIA), 42 U.S.C. §263a, That Meet The Requirements To Perform High, Moderate Or Waived Complexity Tests. Testing Of Fingerstick Whole Blood Specimens Is Authorized For Use At The Point Of Care (POC), I.e., In Patient Care Settings Operating Under A CLIA Certificate Of Waiver, Certificate Of Compliance, Or Certificate Of Accreditation.

  • • This Test Has Been Authorized Only For The Presence Of IgM And IgG Antibodies Against SARS-CoV-2, Not For Any Other Viruses Or Pathogens; And

  • • This Test Is Only Authorized For The Duration Of The Declaration That Circumstances Exist Justifying The Authorization Of Emergency Use Of In Vitro Diagnostics For Detection And/or Diagnosis Of COVID-19 Under Section 564(b)(1) Of The Act, 21 U.S.C. § 360bbb-3(b)(1), Unless The Authorization Is Terminated Or Revoked Sooner.

Especificaciones Especificaciones y medidas de los productos

  • Brand
    Premier RightSign
  • CLIA Classification
    CLIA Waived
  • Item
    Test Kit
  • Item Type
    COVID-19 IgG/IgM

Description du catalogue Tal como se ve en nuestro catálogo impreso

A rapid chromatographic immunoassay for the qualitative detection and differentiation of IgG and IgM antibodies to SARS-CoV-2 in human venous whole blood, serum or plasma, or fingerstick whole blood. The test is intended for use as an aid in identifying individuals with adaptive immune response to SARS-CoV-2, indicating recent or prior infection. CLIA waived.

ARTIST: Add these two lines to first part of note (NOTE field is too large)
This test has not been FDA cleared or approved.
This test is authorized by FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories only.

Continuar comprando Añadir
Henry Schein Henry Schein